Kelsi Sandoz, Ph.D.
Affiliations: | 2011 | Oregon State University, Corvallis, OR |
Area:
Molecular Biology, Microbiology Biology, Pharmaceutical ChemistryGoogle:
"Kelsi Sandoz"Parents
Sign in to add mentor| Daniel D. Rockey | grad student | 2011 | Oregon State | |
| (Recombination, Resistance, and Drug Discovery in Chlamydia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sandoz KM, Valiant WG, Eriksen SG, et al. (2014) The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells. Antimicrobial Agents and Chemotherapy. 58: 3860-6 |
| Jeffrey BM, Suchland RJ, Eriksen SG, et al. (2013) Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants. Bmc Microbiology. 13: 142 |
| Sandoz KM, Eriksen SG, Jeffrey BM, et al. (2012) Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY. Antimicrobial Agents and Chemotherapy. 56: 4296-302 |
| Beare PA, Sandoz KM, Omsland A, et al. (2011) Advances in genetic manipulation of obligate intracellular bacterial pathogens. Frontiers in Microbiology. 2: 97 |
| Sandoz KM, Rockey DD. (2010) Antibiotic resistance in Chlamydiae. Future Microbiology. 5: 1427-42 |
| Suchland RJ, Sandoz KM, Jeffrey BM, et al. (2009) Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. Antimicrobial Agents and Chemotherapy. 53: 4604-11 |